MAPRE1 and polycystic ovary syndrome: One of the newer large-scale genome-wide association studies (GWAS) linking more than 10,000,000 genetic markers in 10,074 European women with PCOS and 103,164 controls revealed three new loci (near PLGRKT, ZBTB16, and MAPRE1) associated with PCOS risk.